Chauvenet P H, Amos D B, Smith R T
J Immunogenet. 1978 Jun;5(3):179-91. doi: 10.1111/j.1744-313x.1978.tb00644.x.
Asymmetry in the relationship between the H-2K mutant strain C57Bl/6.CH-2ba (H-2ba) and the wild-type congenic C57Bl/6 has been demonstrated both in MLR and serologically by haemagglutination. MLR between these strains, when B6 was the responder, was as strong as that toward allogeneic stimulator cells: H-2ba was regularly less responsive toward B6. Responses in both directions were increased, in terms of augmented proliferative responses, by prior immunization. In this context the MLR resembles that towards minor H-locus antigens rather than those controlled by the H-2 locus. Immunization of (H-2ba X BALB/c)F1 hybridgs with B6 lymphoid cells induced the production of a haemagglutinating antibody not directed toward any known H-2 specificity. The B6 haemagglutinogen, termed He, was present on B6 lymphoid as well as red blood cells. Segregation studies of F2 and back-cross progeny of (H-2ba X BALB/c)F1 hybrids suggest that the response to He is controlled by two Ir genes, one of which is linked to H-2.
H-2K突变株C57Bl/6.CH-2ba(H-2ba)与野生型同基因C57Bl/6之间关系的不对称性已在混合淋巴细胞反应(MLR)中以及通过血凝反应的血清学方法得到证实。当B6作为反应细胞时,这些品系之间的MLR与对同种异体刺激细胞的反应一样强烈:H-2ba对B6的反应通常较弱。通过预先免疫,从增殖反应增强的角度来看,双向反应均增强。在这种情况下,MLR类似于对次要组织相容性位点(H)抗原的反应,而不是由H-2位点控制的反应。用B6淋巴细胞免疫(H-2ba×BALB/c)F1杂种诱导产生了一种血凝抗体,该抗体不针对任何已知的H-2特异性。称为He的B6血凝原存在于B6淋巴细胞以及红细胞上。对(H-2ba×BALB/c)F1杂种的F2和回交后代的分离研究表明,对He的反应由两个免疫反应基因(Ir基因)控制,其中一个与H-2连锁。